Insulin delivery devices market has been quickly growing since its beginning in late 1970's; at the time first insulin pump was produced. Post-introduction of first gadget, the industry has experienced a quick advancement as far as expanding number of organizations growing new items, for example, reusable pens, safe needles, and so forth. In spite of the fact that being in the development stage, the industry is still yet to experience the launch of novel items, for example, tubeless insulin pumps. Right now, just bunch of organizations offer tubeless insulin pumps, and many are in procedure to dispatch their rendition of pumps in market in not so distant future.
Insulin Delivery Devices Market measure was esteemed over US$10,160 mn in 2016 and is relied upon to experience over 8.6% CAGR from 2017 to 2025. Expanding interest for insulin conveying devices and negligibly intrusive choices, for example, siphons, headways in insulin devices as far as structure and working, expanding pervasiveness of diabetes and straightforwardness offered by some insulin delivery devices to patients are a portion of the real market development driving variables watched around the world. Additionally, raising pervasiveness of diabetes is the unmistakable explanation for insulin delivery devices market extension.
Insulin Pens Make Highly Profitable Product Segment
Based on product, the insulin delivery devices market, has been segmented into insulin patches, insulin pens, insulin pumps, needle-free injection jet, and insulin syringes. Among these, insulin pens category is accounted for almost half of the total revenue in the recent years. Also, it is expected to continue the most profitable product category in the forthcoming year.
Insulin pen is most commonly used in insulin delivery devices range; in fact, its market held the maximum revenue share of the total industry in the past few years. Being accessible since late 1980's, its business has developed into a multi-billion-dollar market and is relied upon to stand out in the upcoming years. Insulin pen implementation is well on the way to develop in creating countries having more than normal diabetes patients in low pay group.
North American Market is Accounted for Highly Profitable, due to rising diabetes occurrences
U.S. insulin delivery devices market was leading the insulin delivery device market with its maximum regional revenue shares in the past few years. Expanding diabetes occurrences combined with rising per capita income of people will drive market development in the forthcoming years. Development in technology in insulin delivery devices market alongside positive government activities to execute better diabetes will additionally fuel industry development.
The insulin delivery devices market in Germany held almost 1/3rd of the insulin delivery device market. Extending old-age populace base, favorable reimbursement policies, rising frequency of diabetes, and expanding per capita income will fill in as high effect rendering factors. China insulin delivery devices market was also heading to lead the market and it foreseen to observer around 14% development in the forthcoming year. With its enormous diabetic populace and quick financial advancement, the nation spends nearly USD 25 bn for treating diabetes related illnesses every year.
In any case, just about 35% of diabetic populace knows about being diabetic and are getting treatment for their condition, while rest are undiscovered. Improvement in analysis rate and expanded mindfulness towards early finding will drive interest for insulin delivery devices over the figure time frame.
The major companies operating in the insulin delivery devices market which are Owen Mumford Ltd., Biocon Ltd., Cellnovo Group SA., Johnson & Johnson, Animas Corporation, and Tandem Diabetes Care, Inc.
Global Insulin Delivery Devices Market: Overview
This report on insulin delivery devices market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of insulin delivery devices such as insulin pen and insulin pumps as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global insulin delivery devices market with respect to the leading market segments based on major products segment, distribution channels, and geographies.
Global Insulin Delivery Devices Market: Key Segments
Based on the product type, the insulin delivery devices market has been segmented into: insulin syringe, insulin pens, insulin pumps, and others (insulin patches & needle free injection jet). Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of diabetes incidences worldwide, technological advancement, and growing number of use of insulin delivery devices in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Insulin Delivery Devices Market: Trends and Opportunities
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the insulin delivery devices market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global insulin delivery devices market.
Global Insulin Delivery Devices Market: Geographical Segmentation
Geographically, insulin delivery devices market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, pricing analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global insulin delivery devices market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global insulin delivery devices market.
Global Insulin Delivery Devices Market: Competitive Landscape
The report also profiles key players operating in the insulin delivery devices market which are B. Braun Melsungen AG, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Medtronic plc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Biocon Ltd., Owen Mumford Ltd., Cellnovo Group SA., Animas Corporation (Johnson & Johnson , Tandem Diabetes Care, Inc., Other Prominent Players.
The global insulin delivery devices market is segmented as follows:
Insulin Delivery Devices Market, by Product Type
- Insulin syringe
- Insulin Pens
- Disposable Pens
- Reusable Pens
- Pen Needles
- Insulin Pumps
- Tethered Insulin Pumps
- Disposable/Patch Insulin Pumps
- Others (insulin Patches & Needle Free Injection Jet)
Insulin Delivery Devices Market, by Distribution Channels
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
Insulin Delivery Devices Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa